General Information
Product name
Megestrol Acetate Suspension
Chemical name
17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione acetate
CAS No.
595-33-5
1.2.1 Relevant identified uses
Anorexia, cachexia, or an unexplained, significant weight loss in patients
Manufacturer Name
VistaPharm, Inc
Icons in SDS
Company Information
company name
VistaPharm, Inc
Section 2
SECTION 2: Hazards identification
WARNING STATEMENT CAUTION: Contains megestrol acetate, a pharmaceutically active pharmaceutical ingredient intended for clinical use only. This product may pose a health hazard only if exposure occurs to liquid contents, e.g., after spill or leak. Overexposure to megestrol acetate, the active ingredient, may affect the developing fetus and impair fertility. Repeated overexposure may cause an increased risk of cancer based on the results of animal studies. Avoid skin contact, eye contact, and inhalation. Routes of Absorption: Skin contact, eye contact, inhalation, and accidental ingestion. Eye and Skin: No data available on skin and eye irritation. Repeated skin contact may cause an allergic skin reaction. Systemic: As a liquid, the potential for exposure is limited unless the contents are released by spill or breakage. When used clinically, megestrol acetate is considered a developmental toxicant (potentially causes effects on the developing fetus) and reproductive toxicant (potentially causes effects on male and female fertility). May cause cancer based on positive studies in laboratory animals.
Medical Conditions Generally Aggravated by Exposure
None known or reported. Occupational Exposure None currently established by OSHA, NIOSH, or ACGIH for the active Limit: ingredient, megestrol acetate.